Head, Oncology Immune Therapeutics

#LI-Onsite

Location:

Cambridge, MA, United States Relocation Support:
Yes

Step into a pivotal leadership role at the forefront of oncology innovation, where your work will directly shape the future of cancer treatment. As Head, Oncology Immune Therapeutics, you will define and lead the global research and drug discovery strategy across cutting‑edge modalities including cell and gene therapies, immune cell engager therapies, and next‑generation biologics.

You will partner across a highly collaborative scientific ecosystem to translate bold ideas into breakthrough therapies, driving a high‑impact portfolio from early discovery through development candidate selection. This is a unique opportunity to combine deep scientific expertise with strategic influence, building and leading a world‑class team while delivering meaningful advances for patients worldwide.

• Define and execute the global immuno‑oncology research and drug discovery strategy across multiple therapeutic modalities
• Lead end‑to‑end discovery programs from hypothesis through development candidate nomination and regulatory readiness
• Drive a high‑impact oncology pipeline spanning exploratory research, optimization, and clinical‑enabling activities
• Provide scientific and strategic leadership across cross‑functional teams to advance oncology immune therapeutic programs
• Shape and prioritize a competitive research portfolio through data‑driven decision making and resource allocation
• Partner with senior stakeholders to align strategy across research, development, commercial, and strategic functions
• Lead external innovation through evaluation and execution of business development and collaboration opportunities
• Establish and advance new scientific directions in immuno‑oncology, including novel targets and therapeutic approaches
• Build, lead, and develop a high‑performing global organization with deep expertise in cell therapy and immuno‑oncology
• Represent the oncology immune therapeutics strategy and portfolio to executive leadership and external scientific communities

• Doctor of Philosophy (PhD) or Medical Doctor (MD) in oncology, immunology, biology or related scientific field
• Deep expertise in immuno‑oncology and cell therapy, including experience with chimeric antigen receptor T‑cell therapies
• Proven track record leading end‑to‑end oncology research from discovery through development candidate nomination
• Extensive experience advancing biologics, cell therapies, or gene therapies to Investigational New Drug enabling stage
• Demonstrated leadership of large, multidisciplinary scientific teams and development of senior talent
• Strong scientific credibility with a record of high‑impact publications as senior or corresponding author
• Strategic mindset with ability to make data‑driven portfolio and investment decisions across complex programs
• Broad industry knowledge and external network across oncology research, clinical development, and biotechnology landscape

• Experience leading external scientific collaborations, partnerships, or business development evaluations in oncology therapeutics
• Track record of shaping enterprise‑wide research strategy and influencing senior decision forums across a global matrix

• Salary range: $ – $ USD per year (actual offer based on skills, experience, and periodic review)
• Performance‑based cash incentive and eligibility for annual equity awards
• Comprehensive benefits package including health, life and disability benefits, 401(k) with company contribution and match, and other benefits
• Generous time‑off package: vacation, personal days, holidays and other leaves